Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP577111.RAm8SX_t-pmrbDNRSfe9DqW2wnb3SWU48b_Iy9cPe37-k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP577111.RAm8SX_t-pmrbDNRSfe9DqW2wnb3SWU48b_Iy9cPe37-k130_assertion type Assertion NP577111.RAm8SX_t-pmrbDNRSfe9DqW2wnb3SWU48b_Iy9cPe37-k130_head.
- NP577111.RAm8SX_t-pmrbDNRSfe9DqW2wnb3SWU48b_Iy9cPe37-k130_assertion wasGeneratedBy ECO_0000203 NP577111.RAm8SX_t-pmrbDNRSfe9DqW2wnb3SWU48b_Iy9cPe37-k130_provenance.
- NP577111.RAm8SX_t-pmrbDNRSfe9DqW2wnb3SWU48b_Iy9cPe37-k130_assertion wasDerivedFrom befree-20150227 NP577111.RAm8SX_t-pmrbDNRSfe9DqW2wnb3SWU48b_Iy9cPe37-k130_provenance.
- NP577111.RAm8SX_t-pmrbDNRSfe9DqW2wnb3SWU48b_Iy9cPe37-k130_assertion SIO_000772 15988530 NP577111.RAm8SX_t-pmrbDNRSfe9DqW2wnb3SWU48b_Iy9cPe37-k130_provenance.
- NP577111.RAm8SX_t-pmrbDNRSfe9DqW2wnb3SWU48b_Iy9cPe37-k130_assertion evidence source_evidence_literature NP577111.RAm8SX_t-pmrbDNRSfe9DqW2wnb3SWU48b_Iy9cPe37-k130_provenance.
- NP577111.RAm8SX_t-pmrbDNRSfe9DqW2wnb3SWU48b_Iy9cPe37-k130_assertion description "[The clinical success of the ABL tyrosine kinase inhibitor imatinib in chronic myeloid leukaemia (CML) serves as a model for molecularly targeted therapy of cancer, but at least two critical questions remain.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP577111.RAm8SX_t-pmrbDNRSfe9DqW2wnb3SWU48b_Iy9cPe37-k130_provenance.